Significant reduction in chronic kidney disease progression with sodium‐glucose cotransporter‐2 inhibitors compared to dipeptidyl peptidase‐4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease

AIMS: To confirm the reno‐protective effects of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors on the onset and progression of chronic kidney disease (CKD) in routine clinical practice. MATERIALS AND METHODS: We conducted a retrospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Idris, Iskandar, Zhang, Ruiqi, Mamza, Jil B., Ford, Mike, Morris, Tamsin, Banerjee, Amitava, Khunti, Kamlesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795968/
https://www.ncbi.nlm.nih.gov/pubmed/35676798
http://dx.doi.org/10.1111/dom.14799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795968/
https://www.ncbi.nlm.nih.gov/pubmed/35676798
http://dx.doi.org/10.1111/dom.14799

Ejemplares similares